Beneficial effect of refined red palm oil on lipid peroxidation and monocyte tissue factor in HCV-related liver disease: A randomizer controller study

Hepatobiliary and Pancreatic Diseases International

Volumn 15, Issue 2, 2016, Pages 165-172

  Catanzaro, Roberto ^a,g   Zerbinati, Nicola ^b   Solimene, Umberto ^c   Marcellino, Massimiliano ^d   Mohania, Dheeraj ^e   Italia, Angelo ^a   Ayala, Antonio ^f   Marotta, Francesco ^d  

^a UNIVERSITY OF CATANIA   (Italy)

^b CMP Medical Center   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d ReGenera Research Group for Aging Intervention and San Babila Clinic   (Italy)

^e SIR GANGA RAM HOSPITAL   (India)

^f UNIVERSITY OF SEVILLE   (Spain)

^g UNIVERSITY OF CATANIA   (Italy)

Author keywords

endotoxin; isoprostane; macrophage colony stimulating factor; monocyte tissue factor; oxidative stress; red palm oil

Indexed keywords

ALPHA TOCOPHEROL; COLONY STIMULATING FACTOR 1; CYTOKINE; ENDOTOXIN; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; RED PALM OIL; THROMBOPLASTIN; AUTACOID; PALM OIL; VEGETABLE OIL;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DOWN REGULATION; ENDOTOXEMIA; ERYTHROCYTE LEVEL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; URINARY EXCRETION; ADVERSE EFFECTS; CELL CULTURE; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; ERYTHROCYTE; ITALY; LIVER; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; TIME FACTOR; TREATMENT OUTCOME; URINE; VIROLOGY;

AGED; CELLS, CULTURED; DIETARY SUPPLEMENTS; ERYTHROCYTES; FEMALE; HEPATITIS C; HUMANS; INFLAMMATION MEDIATORS; ISOPROSTANES; ITALY; LIPID PEROXIDATION; LIVER; LIVER CIRRHOSIS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MALONDIALDEHYDE; MIDDLE AGED; MONOCYTES; OXIDATIVE STRESS; PLANT OILS; THROMBOPLASTIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84962696405     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(16)60072-3     Document Type: Article

References (43)

1. GB Gaeta, P Perna, LE Adinolfi, R Utili, G Ruggiero Endotoxemia in a series of 104 patients with chronic liver diseases: prevalence and significance Digestion 23 1982 239 244
2. K Tarao, K So, T Moroi, T Ikeuchi, T Suyama Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance Gastroenterology 73 1977 539 542
3. AB Lumsden, JM Henderson, MH Kutner Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis Hepatology 8 1988 232 236
4. S Bengmark Bio-ecological control of chronic liver disease and encephalopathy Metab Brain Dis 24 2009 223 236
5. A Kuhla, J Norden, K Abshagen, MD Menger, B Vollmar RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failure Br J Surg 100 2013 1229 1239
6. S De Minicis, C Rychlicki, L Agostinelli, S Saccomanno, C Candelaresi, L Trozzi et al. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice Hepatology 59 2014 1738 1749
7. KC Lee, YY Yang, YW Wang, FY Lee, CC Loong, MC Hou et al. Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure Dig Dis Sci 55 2010 2077 2085
8. A Amer, ME Amer Enhanced monocyte tissue factor expression in hepatosplenic schistosomiasis Blood Coagul Fibrinolysis 13 2002 43 47
9. D Heredia, J Caballería, V Arroyo, G Ravelli, J Rodés Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial J Hepatol 4 1987 293 298
10. O Riggio, G Balducci, F Ariosto, M Merli, S Tremiterra, V Ziparo et al. Lactitol in the treatment of chronic hepatic encephalopathy-a randomized cross-over comparison with lactulose Hepatogastroenterology 37 1990 524 527
11. H Jaeschke Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts J Gastroenterol Hepatol 26 2011 173 179
12. A Ramachandran, R Prabhu, S Thomas, JB Reddy, A Pulimood, KA Balasubramanian Intestinal mucosal alterations in experimental cirrhosis in the rat: role of oxygen free radicals Hepatology 35 2002 622 629
13. ES Musiek, H Yin, GL Milne, JD Morrow Recent advances in the biochemistry and clinical relevance of the isoprostane pathway Lipids 40 2005 987 994
14. S Basu Isoprostanes: novel bioactive products of lipid peroxidation Free Radic Res 38 2004 105 122
15. S Devaraj, D Li, I Jialal The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium J Clin Invest 98 1996 756 763
16. M Nakamura, H Saito, M Ikeda, R Hokari, N Kato, T Hibi et al. An antioxidant resveratrol significantly enhanced replication of hepatitis C virus World J Gastroenterol 16 2010 184 192
17. G Szucs, DJ Bester, K Kupai, T Csont, C Csonka, AJ Esterhuyse et al. Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats Lipids Health Dis 10 2011 103
18. YG Aboua, N Brooks, RZ Mahfouz, A Agarwal, SS du Plessis A red palm oil diet can reduce the effects of oxidative stress on rat spermatozoa Andrologia 44 2012 32 40
19. AF Subar, FE Thompson, V Kipnis, D Midthune, P Hurwitz, S McNutt et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study Am J Epidemiol 154 2001 1089 1099
20. H Fukui, B Brauner, JC Bode, C Bode Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay J Hepatol 12 1991 162 169
21. C Bode, H Fukui, JC Bode "Hidden" endotoxin in plasma of patients with alcoholic liver disease Eur J Gastroenterol Hepatol 5 1993 247 262
22. H Fukui, B Brauner, JC Bode, C Bode Chromogenic endotoxin assay in plasma. Selection of plasma pretreatment and production of standard curves J Clin Chem Clin Biochem 27 1989 941 946
23. H Fukui, S Tsujita, M Matsumoto, M Morimura, H Kitano, K Kinoshita et al. Endotoxin inactivating action of plasma in patients with liver cirrhosis Liver 15 1995 104 109
24. T Hanamura, K Motoyoshi, K Yoshida, M Saito, Y Miura, T Kawashima et al. Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay Blood 72 1988 886 892
25. PJ Shadle, JI Allen, MD Geier, K Koths Detection of endogenous macrophage colony-stimulating factor (M-CSF) in human blood Exp Hematol 17 1989 154 159
26. TA Mori, KD Croft, IB Puddey, LJ Beilin An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry Anal Biochem 268 1999 117 125
27. SK Jain Membrane lipid peroxidation in erythrocytes of the newborn Clin Chim Acta 161 1986 301 306
28. DJ Ruiter, J van der Meulen, A Brouwer, MJ Hummel, BJ Mauw, JC van der Ploeg et al. Uptake by liver cells of endotoxin following its intravenous injection Lab Invest 45 1981 38 45
29. RS Lin, FY Lee, SD Lee, YT Tsai, HC Lin, RH Lu et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation J Hepatol 22 1995 165 172
30. Y Itoh, T Okanoue, F Enjo, S Sakamoto, K Keizo, O Yasukazu et al. Macrophage colony stimulating factor and hepatitis Int Hepatol Commun 1 1993 1 4
31. MJ Czaja, A Geerts, J Xu, P Schmiedeberg, Y Ju Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease J Leukoc Biol 55 1 1994 Jan 120 126
32. C Müller, CC Zielinski Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis J Hepatol 15 1992 372 377
33. J Deviere, J Content, C Denys, P Vandenbussche, L Schandene, J Wybran et al. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production Clin Exp Immunol 77 1989 221 225
34. Y Itoh, T Okanoue, F Enjyo, S Sakamoto, Y Ohmoto, Y Hirai et al. Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease J Hepatol 21 1994 527 535
35. Y Itoh, T Okanoue, S Sakamoto, K Nishioji, K Kashima The effects of prednisolone and interferons on serum macrophage colony stimulating factor concentrations in chronic hepatitis B J Hepatol 26 1997 244 252
36. J Däbritz, E Bonkowski, C Chalk, BC Trapnell, J Langhorst, LA Denson et al. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease Am J Gastroenterol 108 2013 1901 1910
37. Y Itoh, T Okanoue, N Ohnishi, M Sakamoto, K Nishioji, Y Nakagawa et al. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection Am J Gastroenterol 94 1999 1332 1340
38. J Choi, NL Corder, B Koduru, Y Wang Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma Free Radic Biol Med 72 2014 267 284
39. E Serbinova, V Kagan, D Han, L Packer Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol Free Radic Biol Med 10 1991 263 275
40. S Devaraj, I Jialal Failure of vitamin E in clinical trials: is gamma-tocopherol the answer? Nutr Rev 63 2005 290 293
41. L Spahr, S Bresson-Hadni, P Amann, I Kern, O Golaz, JL Frossard et al. Allopurinol, oxidative stress and intestinal permeability in patients with cirrhosis: an open-label pilot study Liver Int 27 2007 54 60
42. Y Dotan, D Lichtenberg, I Pinchuk No evidence supports vitamin E indiscriminate supplementation Biofactors 35 2009 469 473
43. GA Asare, B Ntombini, MC Kew, CP Kahler-Venter, EN Nortey Possible adverse effect of high delta-alpha-tocopherol intake on hepatic iron overload: enhanced production of vitamin C and the genotoxin, 8-hydroxy-2'-deoxyguanosine Toxicol Mech Methods 20 2010 96 104